Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Kymera Therapeutics Inc. logo

Kymera Therapeutics Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

40.17
 
USD
  
0.68
  
(1.72%)
Optionable: Yes  Market Cap: 2,413 M  90-day average vol: 803,440

Previous close: 39.49  Open: 39.98  Bid: 39.48  Ask: 42.62
52 week range    
9.60   
   45.31
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Thursday 28th March 2024
54
MarketXLS Rank
60
Value
53
Technical
50
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

KYMR Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-2.09-2.87-2.52
Basic EPS total-2.09-2.87-2.52
Basic weighted shares outstanding17 M48 M54 M58 M
Depreciation-2 M2 M3 M4 M
DepreciationAndAmortization-2 M2 M3 M4 M
Diluted EPS total-3.15-2.09-2.87-2.52
Diluted normalized net income/share-3.15-2.87-2.52
Diluted weighted shares outstanding17 M54 M58 M
GeneralAndAdministrativeExpense18 M36 M44 M55 M
Gross operating profit34 M73 M47 M79 M
Income before tax-46 M-100 M-155 M-147 M
InterestExpenseNonOperating-121000.0158000.0179000.0181000.0
MiscOtherSpecialCharges711000.0313000.06 M19 M
Net income from total operations-55 M-100 M-155 M-147 M
NetIncomeCommonStockholders-55 M-100 M-155 M-147 M
NetIncomeContinuousOperations-55 M-100 M-155 M-147 M
NetNonOperatingInterestIncomeExpense121000.0-158000.0-179000.0-181000.0
Normalized income-116 M
Operating income-46 M-101 M-161 M-166 M
Operating income before depreciation (EBITDA)-44 M-98 M-152 M-143 M
OperatingExpense80 M173 M208 M244 M
Other income net-711000.0-313000.0-6 M-19 M
OtherGandA18 M36 M44 M55 M
OtherOperatingExpenses-3 M4 M5 M13 M
Research & development expense62 M137 M164 M189 M
ResearchExpense62 M137 M164 M189 M
Revenue per share-716000.0906000.01 M2 M
SalariesAndWages-5 M
Selling Gen & administrative expense18 M36 M44 M55 M
Total Income available for interest expense (EBIT)-46 M-100 M-155 M-147 M
Total common shares outstanding45 M52 M55 M61 M
Total net income-55 M-100 M-155 M-147 M
Total ordinary shares61 M61 M61 M61 M
Total revenues34 M73 M47 M79 M
TotalExpenses80 M173 M208 M244 M
TotalRevenue34 M73 M47 M79 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University